MTE #16: Cannabis and Cannabidiol Hepatotoxicity (Ticketed)

Nov 17 2024

Convention Center: Room 33 B

7:00 AM - 7:45 AM

Ticketed Event

World Class Speakers

Melissa Palmer, MD

Discussion Leader

Melissa Palmer, MD

CEO Liver Consulting LLC

Raj Vuppalanchi, MD, FAASLD

Discussion Leader

Raj Vuppalanchi, MD, FAASLD

Indiana University School of Medicine

Description

Speakers discuss the data regarding hepatotoxicity from cannabis and cannabidiol compounds.

Journey Maps

Acute Liver Failure Acute-on-Chronic Liver Failure Drug-Induced Liver Injury

Objectives

Explain the liver toxicity risk associated with cannabis products.
Describe the difference between cannabidiol (CBD) and cannabis in terms of liver injury and relative toxicity.